Senti Biosciences, Inc. (SNTI) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 233.83M |
| Enterprise Value | 246.3M |
| P/E Ratio | -0.22 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 220.05 |
| Price/Book Ratio | -3.56 |
| Enterprise/Revenue | 470.29 |
| Enterprise/EBITDA | -0.53 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -901.16 |
| Operating Margin | -1,027.62 |
| Return On Assets | -1.5 |
| Return On Equity | -15.4 |
| Revenue | 22,000 |
| Revenue/Share | 0 |
| Gross Profit | -3.62M |
| EBITDA | -57.8M |
| Net Income | -61.44M |
| Diluted EPS | -2.73 |
| Total Cash | 6.46M |
| Total Cash/Share | 0.21 |
| Total Debt | 20.23M |
| Total Debt/Equity | -5.95 |
| Current Ratio | 0.83 |
| Book Value Per Share | -0.11 |
| 52-Week Change | -76.45 |
| 52-Week High | 2.88 |
| 52-Week Low | 0.33 |
| Moving Average 50 Days | 0.67 |
| Moving Average 200 Days | 1.03 |
| Average Volume | 259,483 |
| Shares Outstanding | 31.14M |
| % Held by Institutions | 0.97 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | July 18, 2024 |